Medication info
Rovast 5mg (Rosuvastatin Calcium)

Rovast 5mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Hanpung Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201904550 · Approved 2019.07.04 · Insurance code 658106580

Summary

Main use
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and suppression of atherosclerosis progression
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Hanpung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, reduction of cardiovascular disease risk, and suppression of atherosclerosis progression

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • excess LDL cholesterol
  • excess total cholesterol
  • excess Apo-B protein levels
  • dysbetalipoproteinemia
  • excess high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
View approved original text

This medication is primarily used for patients with hypercholesterolemia and hyperlipidemia. It is taken as an adjunct when dietary measures and exercise are insufficient to control cholesterol levels. It helps to reduce serum cholesterol and LDL-cholesterol levels, thus delaying the progression of atherosclerosis. It is also effective as an adjunct therapy for patients with familial hypercholesterolemia or dysbetalipoproteinemia. It may be used in pediatric patients exceeding certain criteria to help control blood lipid levels. Furthermore, it contributes to reducing the risk of stroke, myocardial infarction, and revascularization procedures in men over 50 years and women over 60 years who have specific cardiovascular risk factors. Therefore, this drug is used to reduce the risk of cardiovascular diseases through the management of blood lipids.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This drug should not be used in certain patients. For instance, patients with allergies to any component of this drug, severe liver impairment, muscle diseases, and critically decreased kidney function should not take it. Pregnant or nursing women, as well as women who may become pregnant, must consult a physician before taking this drug and should use appropriate contraceptive methods. Caution is particularly needed with high doses, as they may increase the risk of muscle-related side effects. This drug may affect liver function; therefore, patients with liver disease or those consuming alcohol excessively should have regular liver function tests both before and during treatment. Conditions such as hypothyroidism or nephrotic syndrome must be managed prior to treatment. If symptoms such as muscle pain, weakness, or cramps occur, medical staff should be notified immediately, and blood tests may be necessary to check for muscle damage. If muscle enzyme levels rise significantly above normal, the medication should be discontinued. This drug may interact with certain medications; thus, it is essential to inform the physician or pharmacist if other medications are being taken. In particular, the risk of muscle damage may increase when used with certain antibiotics, antifungals, immunosuppressants, and fibrate class drugs. Safety has not been established for pregnant and nursing women; therefore, during treatment with this drug, it is advisable to avoid planning a pregnancy or taking it if pregnant, and nursing mothers should consult experts. In the event of an overdose, there is no specific antidote, so appropriate treatment and monitoring of liver function and muscle enzyme levels based on symptoms are necessary. Caution is needed when driving or operating machinery, as dizziness may occur. If severe skin reactions or allergy symptoms develop during treatment with this drug, it should be discontinued immediately, and medical attention sought. Lastly, this drug contains lactose, so patients with lactose intolerance should not take it.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, asthenia, peripheral neuropathy, amnesia, peripheral nerve disease, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best stored at room temperature between 1°C and 30°C, away from extremes of temperature.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.